Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the ...
By Arasu Kannagi Basil Feb 24 (Reuters) - Medtronic's MiniMed Group said on Tuesday it was targeting up to $7.86 billion valuation in its U.S. initial public offering, marking a step forward in the ...
Medtronic said today that the separation of its MiniMed Diabetes unit remains on track as it advances the MiniMed Flex system ...
Medtronic's diabetes spin-off MiniMed seeks $784M IPO at $7.86B valuation after six quarters of double-digit growth in booming CGM market.
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced the U.S. Food ...
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily ...
(RTTNews) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system. The MiniMed 780G system now offers more ...
In an amendment to an SEC filing, Medtronic's Diabetes unit, MiniMed, today priced its planned initial public offering (IPO).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results